In vitro expansion of hematopoietic progenitor cells induces functional expression of Fas antigen (CD95)

Blood

Volumn 88, Issue 8, 1996, Pages 2871-2877

  Takenaka, Katsuto ^a   Nagafuji, Koji ^b   Harada, Mine ^b   Mizuno, Shin Ichi ^b   Miyamoto, Toshihiro ^b   Makino, Shigeyoshi ^b   Gondo, Hisashi ^b   Okamura, Takashi ^b   Niho, Yoshiyuki ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; ERYTHROPOIETIN; FAS ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 3; INTERLEUKIN 6; STEM CELL FACTOR;

ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BURST FORMING UNIT E; CELL PROLIFERATION; CELL SURVIVAL; COLONY FORMING UNIT GM; ETIOLOGY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0029961350     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.8.2871.bloodjournal8882871     Document Type: Article

References (48)

1. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 26:239, 1972
2. Wyllie AH, Kerr JFR, Currie AR: Cell death: The significance of apoptosis. Int Rev Cytol 68:251, 1980
3. Koury MJ: Programmed cell death (apoptosis) in hematopoiesis. Exp Hematol 20:391, 1992
4. Mangan DF, Welch GR, Wahl SM: Lipopolysaccharide, tumor necrosis factor-α, and IL-1β prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J Immunol 146:1541, 1991
5. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C: Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 83:865, 1989
6. Stern M, Meagher L, Savill J, Haslett C: Apoptosis in human eosinophils. Programmed cell death in the eosinopil leads to phagocytosis by macrophage and is modulated by IL-5. J Immunol 148:3543, 1992
7. Koury MJ, Bondurant MC: Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 248:378, 1990
8. Williams GT, Smith CA, Spooncer E, Dexter TM, Taylor DR: Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343:76, 1990
9. Suda T, Suda J, Ogawa M, Ihle JN: Permissive role of interleukin 3 (IL-3) in proliferation and differentiation of multipotential hemopoietic progenitors in culture. J Cell Physiol 124:182, 1985
10. Katayama N, Clark SC, Ogawa M: Growth factor requirement for survival in cell-cycle dormancy of primitive murine lymphohematopoietic progenitors. Blood 81:610, 1993
11. Brandt JE, Bhalla K, Hoffman R: Effects of interleukin-3 and c-kit ligand on the survival of various classes of human hematopoietic progenitor cells. Blood 83:1507, 1994
12. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233, 1991
13. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhein J, Trauth BC, Ponstingl H, Krammer PH: Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem 267:10709, 1992
14. Yonehara S, Ishii A, Yonehra M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747, 1989
15. Nagata S, Golstein P: The Fas death factor. Science 267:1449, 1995
16. Korsmeyer SJ: Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 80:879, 1992
17. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267:1456, 1995
18. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ: BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88:6961, 1991
19. Iwai K, Miyawaki T, Takizawa T, Konno A, Ohta K, Yachie A, Seki H, Taniguchi N: Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 84:1201, 1994
20. Nuñz G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ: Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 144:3602, 1990
21. Fairbairn LJ, Cowling GJ, Reipert BM, Dexter TM: Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell 74:823, 1993
22. Nagafuji K, Shibuya T, Harada M, Mizuno S, Takenaka K, Miyamoto T, Okamura T, Gondo H, Niho Y: Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 86:883, 1995
23. + human marrow cells is induced by interferon y and tumor necrosis factor α and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 85:3183, 1995
24. + T cells, and monocytes. Cell Immunol 163:303, 1995
25. Taniguchi S, Shibuya T, Morioka E, Okamura T, Okamura S, Inaba S, Niho Y: Demonstration of three distinct immunological disorders on erythropoiesis in a patient with pure red cell aplasia and autoimmune haemolytic anaemia associated with thymoma. Br J Haematol 68:473, 1988
26. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
27. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169, 1993
28. Ponte P, Ng SY, Engel J, Gunning P, Kedes L: Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res 12:1687, 1984
29. Metcalf D: The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 339:27, 1989
30. Moore MAS: Clinical implications of positive and negative hematopoietic stem cell regulators. Blood 78:1, 1991
31. Ogawa M: Differentiation and proliferation of hematopoietic stem cells. Blood 81:2844, 1993
32. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314, 1992
33. Singer GG, Abbas AK: The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365, 1994
34. Yoshino T, Kondo E, Cao L, Takahashi K, Hayashi K, Nomura S, Akagi T: Inverse expression of bcl-2 protein and Fas antigen in lymphoblasts in peripheral lymph nodes and activated peripheral blood T and B lymphocytes. Blood 83:1856, 1994
35. Tanaka M, Suda T, Takahashi T, Nagata S: Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J 14:1129, 1995
36. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S: Expression of the Fas ligand in cells of T cell lineage. J Immunol 154:3806, 1995
37. Kägi D, Vignaux F, Ledermenn B, Burki K, Depraetere V, Nagata S, Hengartner H, Goldstein P: Fas and perform pathways as major mechanisms of T-cell mediated cytotoxicity. Science 265:528, 1994
38. Lowin B, Hahne M, Mattmann C, Tschopp J: Cytotoxic T-cell cytotoxicity is mediated through perform and Fas lytic pathways. Nature 370:650, 1994
39. Hoffman R, Zanjani ED, Lutton JD, Zalusky R, Wasserman LR: Suppression of erythroid-colony formation by lymphocytes from patients with aplastic anemia. N Engl J Med 296:10, 1977
40. Nissen C, Cornu P, Gratwohl A, Speck B: Peripheral blood cells from patients with aplastic anaemia in partial remission suppress growth of their own bone marrow precursors in culture. Br J Haematol 45:233, 1980
41. Zoumbos NC, Gascón P, Djeu JY, Trost SR, Young NS: Circulating activated suppressor T lymphocytes in aplastic anemia. N Engl J Med 312:257, 1985
42. Loughran TP Jr: Clonal diseases of large granular lymphocytes. Blood 82:1, 1993
43. Koizumi S, Seki H, Tachinami T, Taniguchi M, Matsuda A, Taga K, Nakarai T, Kato E, Taniguchi N, Nakamura H: Malignant clonal expansion of large granular lymphocytes with a Leu-11+, Leu-7 -surface phenotype: In vitro responsiveness of malignant cells to recombinant human interleukin 2. Blood 68:1065, 1986
44. Williamas DA: Ex vivo expansion of hematopoietic stem and progenitor cells - Robbing Peter to pay Paul? Blood 81:3169, 1993
45. + cells from patients with stage IV breast cancer. Blood 84:3567, 1994
46. + -selected human peripheral blood progenitor cells. Blood 84:2898, 1994
47. Koller MR, Palsson MA, Manchel I, Palsson BØ: Long-term culture-initiating cell expansion is dependent on frequent medium exchange combined with stromal and other accessory cell effects. Blood 86:1784, 1995
48. Brugger W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L: Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 333:283, 1995